BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 26621191)

  • 1. A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents. [Corrected].
    Wang H; Agarwal P; Zhao S; Yu J; Lu X; He X
    Nat Commun; 2015 Dec; 6():10081. PubMed ID: 26621191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From The Mine to Cancer Therapy: Natural and Biodegradable Theranostic Silicon Nanocarriers from Diatoms for Sustained Delivery of Chemotherapeutics.
    Maher S; Kumeria T; Wang Y; Kaur G; Fathalla D; Fetih G; Santos A; Habib F; Evdokiou A; Losic D
    Adv Healthc Mater; 2016 Oct; 5(20):2667-2678. PubMed ID: 27594524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The advantage of hollow mesoporous carbon as a near-infrared absorbing drug carrier in chemo-photothermal therapy compared with IR-820.
    Zhao Q; Wang X; Yan Y; Wang D; Zhang Y; Jiang T; Wang S
    Eur J Pharm Sci; 2017 Mar; 99():66-74. PubMed ID: 27916695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
    Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
    ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid-Activated TAT Peptide-Modified Biomimetic Boron Nitride Nanoparticles for Enhanced Targeted Codelivery of Doxorubicin and Indocyanine Green: A Synergistic Cancer Photothermal and Chemotherapeutic Approach.
    Li H; Fan Y; Shen Y; Xu H; Zhang H; Chen F; Feng S
    ACS Appl Mater Interfaces; 2024 May; 16(19):25101-25112. PubMed ID: 38691046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyrotaxane-based supramolecular theranostics.
    Yu G; Yang Z; Fu X; Yung BC; Yang J; Mao Z; Shao L; Hua B; Liu Y; Zhang F; Fan Q; Wang S; Jacobson O; Jin A; Gao C; Tang X; Huang F; Chen X
    Nat Commun; 2018 Feb; 9(1):766. PubMed ID: 29472567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound, pH, and magnetically responsive crown-ether-coated core/shell nanoparticles as drug encapsulation and release systems.
    Lee SF; Zhu XM; Wang YX; Xuan SH; You Q; Chan WH; Wong CH; Wang F; Yu JC; Cheng CH; Leung KC
    ACS Appl Mater Interfaces; 2013 Mar; 5(5):1566-74. PubMed ID: 23402574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nanoplatform with tumor-targeted aggregation and drug-specific release characteristics for photodynamic/photothermal combined antitumor therapy under near-infrared laser irradiation.
    Xie M; Zhu Y; Xu S; Xu G; Xiong R; Sun X; Liu C
    Nanoscale; 2020 Jun; 12(21):11497-11509. PubMed ID: 32427255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined cancer therapy with hyaluronan-decorated fullerene-silica multifunctional nanoparticles to target cancer stem-like cells.
    Wang H; Agarwal P; Zhao S; Yu J; Lu X; He X
    Biomaterials; 2016 Aug; 97():62-73. PubMed ID: 27162075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomimetic HDL nanoparticle mediated tumor targeted delivery of indocyanine green for enhanced photodynamic therapy.
    Wang Y; Wang C; Ding Y; Li J; Li M; Liang X; Zhou J; Wang W
    Colloids Surf B Biointerfaces; 2016 Dec; 148():533-540. PubMed ID: 27690242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Monitoring and Self-Delivery of Photosensitizer-Doped Nanoparticles for Highly Effective Combination Cancer Therapy in Vitro and in Vivo.
    Zhang J; Liang YC; Lin X; Zhu X; Yan L; Li S; Yang X; Zhu G; Rogach AL; Yu PK; Shi P; Tu LC; Chang CC; Zhang X; Chen X; Zhang W; Lee CS
    ACS Nano; 2015 Oct; 9(10):9741-56. PubMed ID: 26390118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel self-assembled ES-PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P-gp inhibition: In vitro and in vivo evaluation.
    Wang J; Li L; Wu L; Sun B; Du Y; Sun J; Wang Y; Fu Q; Zhang P; He Z
    Eur J Pharm Sci; 2017 Mar; 99():185-192. PubMed ID: 27989702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic Drugs.
    Jiao Y; Sun Y; Tang X; Ren Q; Yang W
    Small; 2015 Apr; 11(16):1962-74. PubMed ID: 25504837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional theranostic nanoplatform for cancer combined therapy based on gold nanorods.
    Chen WH; Yang CX; Qiu WX; Luo GF; Jia HZ; Lei Q; Wang XY; Liu G; Zhuo RX; Zhang XZ
    Adv Healthc Mater; 2015 Oct; 4(15):2247-59. PubMed ID: 26333115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dually pH/Reduction-Responsive Vesicles for Ultrahigh-Contrast Fluorescence Imaging and Thermo-Chemotherapy-Synergized Tumor Ablation.
    Zhu A; Miao K; Deng Y; Ke H; He H; Yang T; Guo M; Li Y; Guo Z; Wang Y; Yang X; Zhao Y; Chen H
    ACS Nano; 2015 Aug; 9(8):7874-85. PubMed ID: 26181349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-conversion nanoparticle assembled mesoporous silica composites: synthesis, plasmon-enhanced luminescence, and near-infrared light triggered drug release.
    Niu N; He F; Ma P; Gai S; Yang G; Qu F; Wang Y; Xu J; Yang P
    ACS Appl Mater Interfaces; 2014 Mar; 6(5):3250-62. PubMed ID: 24521281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor (EGF) fragment-guided anticancer theranostic particles for pH-responsive release of doxorubicin.
    Kang MK; Mao W; Lee JB; Yoo HS
    Int J Pharm; 2017 Mar; 519(1-2):104-112. PubMed ID: 28087384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo.
    Liu Y; Ding X; Li J; Luo Z; Hu Y; Liu J; Dai L; Zhou J; Hou C; Cai K
    Nanotechnology; 2015 Apr; 26(14):145102. PubMed ID: 25789511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.